SCHEMBL19000726

SCHEMBL19000726

O=c1c(Cl)c(Cl)cnn1Cc1c(F)cccc1Cl

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 5/20 0.61
▸ HTT P42858 5/20 0.61
▸ PKM P14618 5/20 0.61
▸ RAB9A P51151 4/20 0.61
▸ KMT2A Q03164 4/20 0.61
▸ MEN1 O00255 3/20 0.61
▸ SMN1; SMN2 Q16637 2/20 0.61
▸ POLB P06746 2/20 0.61
▸ BLM P54132 1/20 0.61
▸ GPR35 Q9HC97 1/20 0.61
▸ MITF O75030 1/20 0.61
▸ ALDH1A1 P00352 4/20 0.54
▸ LMNA P02545 4/20 0.54
▸ CYP1A2 P05177 1/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ CYP2C19 P33261 1/20 0.54
▸ PKLR P30613 2/20 0.53
▸ MAPT P10636 2/20 0.49
▸ RECQL P46063 1/20 0.49
▸ TSHR P16473 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18980129 0.90 RAB9A (0.69) NPSR1HTTPKMRAB9AKMT2A
SCHEMBL19000698 0.81 NPSR1 (0.76) NPSR1HTTPKMRAB9AKMT2A
SCHEMBL19000708 0.80 HTT (0.60) NPSR1HTTPKMRAB9AKMT2A
SCHEMBL19000703 0.79 NPBWR1 (0.64) NPSR1HTTPKMRAB9AKMT2A
SCHEMBL19011573 0.79 RAB9A (0.60) NPSR1HTTPKMRAB9AKMT2A
SCHEMBL10642561 0.76 RAB9A (1.00) NPSR1HTTPKMRAB9AKMT2A
SCHEMBL1691901 0.75 HTT (0.71) NPSR1HTTPKMRAB9AKMT2A
SCHEMBL18979940 0.72 RAB9A (0.62) NPSR1HTTPKMRAB9AKMT2A
SCHEMBL19000706 0.72 HTT (0.77) NPSR1HTTPKMRAB9AKMT2A
SCHEMBL15674013 0.70 HTT (0.59) NPSR1HTTPKMRAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-06-22 — — US disclosed
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-06-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170173008-A1 ANTIMICROBIAL AGENTS AND SCREENING METHODS BAK1, DCLRE1B, BLVRB NPSR1 4642/4885HTT 4458/4885PKM 3271/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback